4//SEC Filing
NephroGenex, Inc. 4
Accession 0001559058-14-000007
CIK 0001338095operating
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:25 PM ET
Size
5.5 KB
Accession
0001559058-14-000007
Insider Transaction Report
Form 4
Hamill John
Chief Financial Officer
Transactions
- Award
Options to Purchase Common Stock
2014-12-12+45,000→ 45,000 totalExercise: $4.67From: 2015-12-12Exp: 2018-12-12→ Common Stock (45,000 underlying)
Documents
Issuer
NephroGenex, Inc.
CIK 0001338095
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338095
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:25 PM ET
- Size
- 5.5 KB